Announcements Trials
Browse Landscape Eligibility

Clinical Trials

3 trials
RecentStart dateEnrollment
Milk × Clear all

Phase

Phase NA 2Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Hypothyroidism 1

Interventions

Cisplatin 3176Cyclophosphamide 3172Carboplatin 2955Radiotherapy 2771Paclitaxel 2705Gemcitabine 2549pembrolizumab 2368Bevacizumab 2192Docetaxel 2190Fluorouracil 1837Capecitabine 1815Oxaliplatin 1723Dexamethasone 1592Nivolumab 1575Doxorubicin 1500Rituximab 1480Magnetic Resonance Spectroscopy 1365Etoposide 1341Irinotecan 1240Leucovorin 1215Drug Therapy 1189Cytarabine 1126Pemetrexed 1067fludarabine 1035Specimen Handling 985Vincristine 964Prednisone 940Cetuximab 938Trastuzumab 936Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT00204477 2024-01-23

Soy Protein and Breast Cancer Risk Reduction

The University of Texas Medical Branch, Galveston

Phase 2 Completed
321 enrolled 14 charts
Breast

Breast Neoplasms

NCT01707056 2021-02-17

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Medstar Health Research Institute

Phase NA Withdrawn
Head & Neck

Hypothyroidism, Thyroid Neoplasms

NCT00597532 2016-04-13

Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study

Memorial Sloan Kettering Cancer Center

Phase NA Completed
140 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡